NC

Nicolas Canouï

Head Of Drug Discovery Platform at AQEMIA

Nicolas Canou has been serving as a communications intern at SAINT LEONARD IMMOBILIER since March 2018 while concurrently studying at Université de Nantes since September 2016. Before this, Nicolas accumulated work experience as a student employee at Super U Brunstatt and Super U Riedisheim from July 2017 to March 2018. Previous internships include a stint at Coste Agency focused on television production and communication assistance, and a role as an event animator at Orange, promoting connected home devices. Additionally, Nicolas has experience as a content writer for Tuxboard. Nicolas holds a Licence in Community Management from Nantes Université and a Licence in Communication and Media Studies from Université Blaise Pascal in Clermont-Ferrand.

Location

Limoges, France

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


AQEMIA

4 followers

AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization. AQEMIA is based in Paris and London.


Industries

Headquarters

IDF, France

Employees

51-200

Links